Polar Asset Management Partners’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Polar Asset Management Partners’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-31,731	Closed	-$117K	–	1137
2023 Q1	$117K	Hold	31,731	–	–	﹤0.01%	678
2022 Q4	$121K	Hold	31,731	–	–	﹤0.01%	795
2022 Q3	$251K	Hold	31,731	–	–	﹤0.01%	841
2022 Q2	$666K	Hold	31,731	–	–	0.01%	787
2022 Q1	$1.19M	Hold	31,731	–	–	0.01%	673
2021 Q4	$1.78M	Hold	31,731	–	–	0.02%	631
2021 Q3	$2.29M	Hold	31,731	–	–	0.03%	546
2021 Q2	$3.04M	Hold	31,731	–	–	0.04%	489
2021 Q1	$4.69M	Buy	+31,731	New	+$5.75M	0.07%	367

Other funds holding NBSE

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prelude Capital Management New York $1.3B AUM 62.01% 1-Year Est. Return

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return